MedPath

Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC

Not Applicable
Not yet recruiting
Conditions
the Incidence of PICC-related Complications
Interventions
Device: PICC
Registration Number
NCT05621473
Lead Sponsor
Shandong Branden Med.Device Co.,Ltd
Brief Summary

This study was designed as a prospective, multicenter, randomized controlled study, with the incidence of postoperative complications as the main observation end point. It was a superiority design.The purpose of this study was to compare the incidence of complications associated with EDUG-guided subcutaneous tunneling and conventional puncture after peripheral vein placement of PICCs

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
420
Inclusion Criteria
  • Age ≥18 years old;

  • Immunocompromised patients, including:

    ① Patients with congenital T cell/B cell deficiency or macrophage disorder;

    ② Patients with solid malignant tumors or hematological malignancies;

    ③ Patients with AIDS;

    ④ Patients undergoing splenectomy or solid organ transplantation;

    ⑤ Patients with rheumatic diseases and treated with immunomodulatory drugs;

  • Follow the doctor's advice to perform PICC catheterization for the first time;

  • No serious cardiovascular disease, such as atrial fibrillation, pulmonary heart disease, severe conduction block, etc., before catheter placement;

  • Patients who have not participated in other clinical studies;

  • Patients who voluntarily participate in the clinical study and can cooperate with the clinical follow-up.

Exclusion Criteria
  • Known allergy to catheter material;
  • History of infection, injury or radiation therapy at the puncture site;
  • There is a history of venous thrombosis or surgical operation at the puncture site;
  • Severe abnormal coagulation function;
  • Superior vena cava compression syndrome;
  • Radical mastectomy for breast cancer or axillary lymph node dissection on the operative side of the limb;
  • Pacemaker and arteriovenous fistula ipsilateral limb.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
trial groupPICCThis arm of patients received tunnel PICC interventions
control groupPICCThis arm of patients received normal PICC interventions
Primary Outcome Measures
NameTimeMethod
rate of PICC-related complications6 months after operation

Observe and record the incidence of catheter-related complications during catheter placement, such as bleeding, subcutaneous congestion, lymphatic exudation, phlebitis (bacterial phlebitis, mechanical phlebitis, thrombophlebitis), infection (local infection, tunneling) Infection, catheter-related bloodstream infection), thrombosis (symptomatic thrombosis, asymptomatic thrombosis), catheter ectopic, medical adhesive-related skin injury, catheter injury and blockage, etc.

Secondary Outcome Measures
NameTimeMethod
rate of unplanned extubationthrough study completion, an average of 4months

the incidence of unplanned extubation

success rate of one-time catheter placementone hour
score of patient comfortone hour
score of operation convenienceone hour
operation timeone hour
time of catheter indwellingIntraoperative (Time from successful catheter insertion to extubation)

Time from successful catheter insertion to extubation

© Copyright 2025. All Rights Reserved by MedPath